On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

DecImmune Therapeutics (United States)

InstitutionResearch output, impact & collaborations

DecImmune Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about DecImmune Therapeutics (United States)?

ScholarIQrecord summary

DecImmune Therapeutics (United States) is a research organisation in Cambridge, US. OpenAlex records 182 works and 16,399 citations for it. 147 researchers list it as their most recent affiliation.

How many works does DecImmune Therapeutics (United States) have?

ScholarIQindexed works

DecImmune Therapeutics (United States) has 182 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for DecImmune Therapeutics (United States) →

How many citations does DecImmune Therapeutics (United States) have?

ScholarIQcitation count

DecImmune Therapeutics (United States) has 16,399 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for DecImmune Therapeutics (United States) →

How many researchers are at DecImmune Therapeutics (United States)?

ScholarIQresearcher count

DecImmune Therapeutics (United States) has 147 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at DecImmune Therapeutics (United States)?

ScholarIQavg h-index

DecImmune Therapeutics (United States) has an average h-index of 82 in OpenAlex.

Open the OpenAlex record →

What is the ROR of DecImmune Therapeutics (United States)?

ScholarIQror

The ROR for DecImmune Therapeutics (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for DecImmune Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for DecImmune Therapeutics (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind DecImmune Therapeutics (United States)?

ScholarIQtop researchers by citations

Doriano Fabbro · PI3K/AKT/mTOR signaling in cancer

349 works29,920 citations

Bing Lim · Pluripotent Stem Cells Research

199 works27,571 citations

What are the most-cited papers on DecImmune Therapeutics (United States)?

ScholarIQmost cited works

Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis

Wen Cai Zhang, Ng Shyh‐Chang, Yang He, Amit Rai, Shivshankar Umashankar, Siming Ma, Boon-Seng Soh, Li Sun, Bee Choo Tai, Min En Nga, Kishore Bhakoo, Senthil Raja Jayapal, Massimo Nichane, Qiang Yu, Dokeu A. Ahmed, Christie Tan, Wong Poo Sing, John Kit Chung Tam, Thirugananam Agasthian, Monireh Soroush Noghabi, Yin Huei Pang, Haw Siang Ang, Wayne Mitchell, Paul Robson, Philipp Kaldis, Ross A. Soo, Sanjay Swarup, Elaine Hsuen Lim, Bing Lim

Cell. 2012677 CitationsOPEN ACCESS

Genomic landscape of lung adenocarcinoma in East Asians

Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, Lidyana Bte Amer, Faranak Ghazi Sherbaf, Chu Quan Tan, Jacob J.S. Alvarez, Bingxin Lu, Jia Qi Lim, Angela Takano, Rahul Nahar, Yin Yeng Lee, Cheryl Zi Jin Phua, Khi Pin Chua, Lisda Suteja, Pauline Jieqi Chen, Mei Mei Chang, Tina Puay Theng Koh, Boon‐Hean Ong, Devanand Anantham, Anne Ann Ling Hsu, Apoorva Gogna, Chow Wei Too, Zaw Win Aung, Yi Fei Lee, Lanying Wang, Tony Kiat Hon Lim, Andreas Wilm, Poh Sum D. Choi, Poh Yong Ng, Chee‐Keong Toh, Wan‐Teck Lim, Siming Ma, Bing Lim, Jin Liu, Wai Leong Tam, Anders J. Skanderup, Joe Yeong, Eng-Huat Tan, Caretha L. Creasy, Daniel S.W. Tan, Axel M. Hillmer, Weiwei Zhai

Nature Genetics. 2020556 Citations

Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia

Yiguo Hu, Yuhua Liu, Shawn D. Pelletier, Elisabeth Buchdunger, Markus Warmuth, Doriano Fabbro, Michael Hallek, Richard A. Van Etten, Shaoguang Li

Nature Genetics. 2004405 CitationsOPEN ACCESS

Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression

Wen Cai Zhang, Tan Min Chin, Henry Yang, Min En Nga, Declan P. Lunny, Edwin Kok Hao Lim, Li Sun, Yin Huei Pang, Yi Ning Leow, Shanneen Rossellini Y Malusay, Priscilla Xin Hui Lim, Jeravan Zili Lee, Benedict Tan, Ng Shyh‐Chang, Elaine Hsuen Lim, Wan Teck Lim, Daniel S.W. Tan, Eng Huat Tan, Bee Choo Tai, Ross A. Soo, Wai Leong Tam, Bing Lim

Nature Communications. 2016216 CitationsOPEN ACCESS

How much of the research on DecImmune Therapeutics (United States) is open access?

ScholarIQopen access share

75%OPEN ACCESS

Gold

25%

Green

Hybrid

Bronze

50%

Closed

25%